Search - tctmd.com

Displaying 81 - 100 of 202

Sort: Relevancy | Date

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

News Daily News

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

Yael L. Maxwell

September 20, 2019

News Industry News

Angel Medical Systems Inc. Assembles World-Class Medical Advisory Board

September 20, 2019

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

September 20, 2019

Early Signs Positive for Tendyne TMVR in Severe MAC

News Daily News

Early Signs Positive for Tendyne TMVR in Severe MAC

September 11, 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

News Industry News

Dassault Systèmes and the FDA Extend Collaboration to Inform Cardiovascular Device Review Process and Accelerate Access to New Treatments

July 24, 2019

Tool May Ease Use of High-Sensitivity Troponin for Acute MI Diagnosis

News Daily News

Tool May Ease Use of High-Sensitivity Troponin for Acute MI Diagnosis

June 28, 2019

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

News Daily News

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

June 26, 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

June 19, 2019

Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation: A Multicenter, Observational, First-in-Human Experience

Presentation TVT 2019

Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation: A Multicenter, Observational, First-in-Human Experience

Presenter: Neil Fam

June 14, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

Burned Out: Experts Recommend Institutional Interventions, Community Understanding to Increase Physician Well-being

News Conference News ACC 2019

Burned Out: Experts Recommend Institutional Interventions, Community Understanding to Increase Physician Well-being

Yael L. Maxwell

March 28, 2019

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

News Daily News

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

March 14, 2019

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

News Conference News CRT 2019

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Yael L. Maxwell

March 04, 2019

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

News Conference News CRT 2019

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

Yael L. Maxwell

March 03, 2019

Marinos Charalambous, MD

News Featured Fellow

Marinos Charalambous, MD

Yael L. Maxwell

January 09, 2019

Top News in Endovascular Therapy: 2018

News Features

Top News in Endovascular Therapy: 2018

December 28, 2018

Top News in Heart Failure: 2018

News Features

Top News in Heart Failure: 2018

December 28, 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

November 15, 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

November 11, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.